SCHEMBL25818528

SCHEMBL25818528

Clc1nc(-c2cccc(-c3ccc4ccc(-c5ccccc5)cc4c3)c2)nc(-c2ccc3sc4ccccc4c3c2)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM3 Q86V86 2/20 0.38
ESR1 P03372 1/20 0.36
ESR2 Q92731 1/20 0.36
LIMK1 P53667 1/20 0.36
CYP1A2 P05177 1/20 0.34
ROCK1 Q13464 1/20 0.34
GPR3 P46089 1/20 0.34
F9 P00740 2/20 0.33
NR1I3 Q14994 1/20 0.33
KDM4E B2RXH2 1/20 0.33
PIK3CA P42336 1/20 0.33
PI4KA P42356 1/20 0.33
PI4KB Q9UBF8 1/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
PIM1 P11309 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26363520 0.95 PIM3 (0.40) PIM3LIMK1CYP1A2ROCK1GPR3
SCHEMBL25818441 0.94 HSD17B1 (0.37) PIM3ESR1ESR2CYP1A2GPR3
SCHEMBL22161533 0.94 HSD17B1 (0.37) PIM3ESR1ESR2CYP1A2GPR3
SCHEMBL22161555 0.94 PIM3 (0.40) PIM3LIMK1CYP1A2ROCK1GPR3
SCHEMBL25818402 0.93 GPR3 (0.33) PIM3LIMK1CYP1A2GPR3F9
SCHEMBL25818423 0.93 ALDH1A1 (0.36) PIM3ESR1ESR2LIMK1GPR3
SCHEMBL23437787 0.92 GPR3 (0.38) PIM3LIMK1CYP1A2ROCK1GPR3
SCHEMBL25817921 0.91 PIM3 (0.40) PIM3ESR1ESR2LIMK1CYP1A2
SCHEMBL22076582 0.90 GPR3 (0.38) PIM3LIMK1CYP1A2ROCK1GPR3
SCHEMBL23437160 0.90 PIM3 (0.42) PIM3LIMK1CYP1A2ROCK1GPR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-02-27 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof NFE2L2, ESR1, OR51E2 PIM3 3432/4885ESR1 2/4885ESR2 14/4885
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF NFE2L2, ESR1, OR51E2 PIM3 3432/4885ESR1 2/4885ESR2 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.